News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,071 Results
Type
Article (13817)
Company Profile (101)
Press Release (252153)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88068)
Career Advice (465)
Deals (15345)
Drug Delivery (67)
Drug Development (36607)
Employer Resources (49)
FDA (6299)
Job Trends (6202)
News (150257)
Policy (14045)
Tag
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (36)
Alliances (23239)
ALS (37)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (42)
Approvals (6339)
Artificial intelligence (113)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (645)
Cardiovascular disease (72)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (90)
Cervical cancer (4)
Clinical research (30946)
Collaboration (352)
Compensation (159)
Complete response letters (17)
COVID-19 (759)
CRISPR (22)
C-suite (128)
Cystic fibrosis (37)
Data (667)
Denatured (15)
Depression (10)
Diabetes (83)
Diagnostics (1325)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (66)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32235)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37603)
Executive appointments (400)
FDA (6741)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (217)
Gene editing (40)
Generative AI (9)
Gene therapy (101)
GLP-1 (350)
Government (1301)
Grass and pollen (3)
Guidances (23)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (35)
Indications (14)
Infectious disease (794)
Inflammatory bowel disease (56)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5881)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (181)
Leadership (4)
Legal (3433)
Liver cancer (19)
Lung cancer (87)
Lymphoma (57)
Machine learning (2)
Management (16)
Manufacturing (163)
MASH (34)
Medical device (1277)
Medtech (1279)
Mergers & acquisitions (9675)
Metabolic disorders (267)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (584)
NextGen: Class of 2025 (1586)
Non-profit (595)
Now hiring (8)
Obesity (152)
Opinion (119)
Ovarian cancer (22)
Pain (54)
Pancreatic cancer (15)
Parkinson's disease (47)
Partnered (7)
Patents (121)
Patient recruitment (30)
Peanut (10)
People (28988)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8055)
Phase II (13092)
Phase III (11748)
Pipeline (471)
Policy (72)
Postmarket research (1401)
Preclinical (3230)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (170)
Real estate (2637)
Recruiting (17)
Regulatory (10141)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (38)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (32)
The Weekly (30)
Vaccines (157)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Today (19)
Last 7 days (283)
Last 30 days (878)
Last 365 days (11689)
2025 (3931)
2024 (12501)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (57)
Arkansas (3)
Asia (20150)
Australia (2616)
California (1785)
Canada (932)
China (248)
Colorado (71)
Connecticut (70)
Delaware (61)
Europe (39524)
Florida (341)
Georgia (39)
Idaho (9)
Illinois (203)
India (16)
Indiana (137)
Iowa (1)
Japan (96)
Kansas (58)
Kentucky (13)
Louisiana (1)
Maine (2)
Maryland (264)
Massachusetts (1538)
Michigan (30)
Minnesota (96)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (787)
New Mexico (7)
New York (533)
North Carolina (404)
North Dakota (2)
Northern California (733)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (460)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (750)
Tennessee (34)
Texas (237)
United States (7466)
Utah (34)
Virginia (79)
Washington D.C. (31)
Washington State (124)
Wisconsin (17)
266,071 Results for "lipella pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
April 8, 2025
·
5 min read
Press Releases
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”
April 23, 2025
·
6 min read
Press Releases
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
February 6, 2025
·
4 min read
Business
Lipella Pharmaceuticals Expands its Advisory Board
Lipella Pharmaceuticals Inc. today announced the expansion of its Scientific Advisory Board to include oncology expertise.
April 17, 2024
·
3 min read
Press Releases
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
February 11, 2025
·
8 min read
Press Releases
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
April 22, 2025
·
7 min read
Drug Development
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Lipella Pharmaceuticals Inc. announces an abstract publication at the 2024 American Society of Clinical Oncology annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online.
May 29, 2024
·
4 min read
Press Releases
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
October 30, 2024
·
1 min read
Press Releases
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
December 3, 2024
·
6 min read
Press Releases
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
November 4, 2024
·
3 min read
1 of 26,608
Next
